Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
ACADIANA, La. (AP) — The Cancer Center of Acadiana is looking for men and women who have been diagnosed with multiple myeloma to participate in a clinical trial to compare the effectiveness of medications.
The Advocate (http://bit.ly/1GK1g1M ) reports the center at Lafayette General Medical Center is comparing the effectiveness of a combination of investigational medications among patients with previously untreated multiple myeloma ineligible for high-dose therapy.
The study is a Phase III clinical trial. Drugs that pass in the category may be approved for use in the general population.
A patient must be 18 and older to participate in the trial.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
